Bank of New York Mellon’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.7M | Buy |
130,714
+3,837
| +3% | +$167K | ﹤0.01% | 2188 |
|
|
2025
Q1 | $3.47M | Sell |
126,877
-216
| -0.2% | -$5.91K | ﹤0.01% | 2405 |
|
|
2024
Q4 | $5.11M | Buy |
127,093
+5,448
| +4% | +$219K | ﹤0.01% | 2270 |
|
|
2024
Q3 | $5.76M | Sell |
121,645
-34,566
| -22% | -$1.64M | ﹤0.01% | 2225 |
|
|
2024
Q2 | $4.66M | Buy |
156,211
+25,317
| +19% | +$756K | ﹤0.01% | 2375 |
|
|
2024
Q1 | $5.26M | Sell |
130,894
-2,697
| -2% | -$108K | ﹤0.01% | 2301 |
|
|
2023
Q4 | $3.4M | Buy |
133,591
+7,327
| +6% | +$187K | ﹤0.01% | 2566 |
|
|
2023
Q3 | $1.76M | Buy |
126,264
+208
| +0.2% | +$2.89K | ﹤0.01% | 2883 |
|
|
2023
Q2 | $2.9M | Sell |
126,056
-839,911
| -87% | -$19.3M | ﹤0.01% | 2627 |
|
|
2023
Q1 | $28.6M | Sell |
965,967
-23,999
| -2% | -$711K | 0.01% | 1356 |
|
|
2022
Q4 | $24.7M | Sell |
989,966
-35,278
| -3% | -$881K | 0.01% | 1420 |
|
|
2022
Q3 | $22.3M | Buy |
1,025,244
+582
| +0.1% | +$12.7K | 0.01% | 1440 |
|
|
2022
Q2 | $20.2M | Buy |
1,024,662
+338,468
| +49% | +$6.66M | ﹤0.01% | 1529 |
|
|
2022
Q1 | $29M | Buy |
686,194
+155,476
| +29% | +$6.58M | 0.01% | 1436 |
|
|
2021
Q4 | $33.7M | Buy |
530,718
+29,838
| +6% | +$1.89M | 0.01% | 1400 |
|
|
2021
Q3 | $29.4M | Buy |
500,880
+432,300
| +630% | +$25.4M | 0.01% | 1490 |
|
|
2021
Q2 | $3.33M | Buy |
68,580
+30,244
| +79% | +$1.47M | ﹤0.01% | 2684 |
|
|
2021
Q1 | $1.49M | Sell |
38,336
-1,924
| -5% | -$74.7K | ﹤0.01% | 3095 |
|
|
2020
Q4 | $2.5M | Buy |
+40,260
| New | +$2.5M | ﹤0.01% | 2710 |
|